Published in Medical Letter on the CDC and FDA, October 16th, 2005
According to recent research from Brazil, "The aim of this study was to evaluate the efficacy of the immunomodulator dehydroepiandrosterone (DHEA) in the treatment of Trypanosoma cruzi infection and the possible biochemistry alterations in male and female Wistar rats.
"DHEA, also known as the steroid of multiple actions, has attracted distinct medical areas. Prior studies show that DHEA enhances immune response against a wide range of viral, bacterial and parasitic pathogens. Furthermore, administration of DHEA seems to protect animals against obesity and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA